Bayer Sevabertinib accepted for review in China for advanced non-small cell lung cancer Ruchika Sharma29 July 2025 11:30 AM ISTBerlin: Bayer has announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has accepted for...
Menopause relief drug: USFDA extends review period for Bayer Elinzanetant Ruchika Sharma27 July 2025 3:45 PM ISTBerlin: Bayer has announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for...
Bayer Nubeqa gets EU nod in third indication for advanced prostate cancer Ruchika Sharma22 July 2025 10:30 AM ISTBerlin: Bayer has received marketing authorization from the European Commission in the European Union (EU) for Nubeqa (darolutamide), an oral...
Bayer extends CEO Bill Anderson contract until 2029 Ruchika Sharma20 July 2025 4:00 PM ISTLeverkusen: The Supervisory Board of Bayer AG has unanimously decided to extend the contract of CEO Bill Anderson until March 31, 2029. His...
CORONA Remedies buys 7 brands from Bayer pharma division in India Ruchika Sharma17 July 2025 2:52 PM ISTAhmedabad: CORONA Remedies has announced the acquisition of seven brands from the pharmaceutical division of Bayer in India.Effective July 16, 2025,...
Bayer gets USFDA nod for Finerenone for new indication in heart failure patients Ruchika Sharma15 July 2025 11:35 AM ISTBerlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for finerenone (Kerendia), a non-steroidal, selective...
Bayer seeks EMA nod for Gadoquatrane Ruchika Sharma13 July 2025 11:30 AM ISTBerlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA) for its...
Bayer gets UK nod for Lynkuet for moderate to severe vasomotor symptoms associated with menopause Ruchika Sharma11 July 2025 11:30 AM ISTBerlin: Bayer has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA, regulatory authority in the UK) for the...
Bayer Eylea 8 mg with extended 6-month treatment interval approved in EU for retinal diseases Ruchika Sharma29 Jun 2025 11:00 AM ISTBerlin: Bayer has received approval from the European Commission (EC) for a label extension in the European Union (EU) for Eylea 8 mg...
EMA Committee recommends marketing nod for Bayer advanced prostate cancer drug darolutamide Ruchika Sharma22 Jun 2025 1:00 PM ISTBerlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...
Bayer seeks USFDA nod for Gadoquatrane for contrast enhanced magnetic resonance imaging of CNS Ruchika Sharma17 Jun 2025 12:44 PM ISTBerlin: Bayer has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its...
Bayer, Broad Institute extend research collaboration to develop new cardiovascular therapies Ruchika Sharma11 Jun 2025 1:15 PM ISTBerlin: Bayer and the Broad Institute have extended their research collaboration of 10 years by an additional five years, to further advance...
